Giulio Sturaro Selected Research

4,4',6-trimethylangelicin

1/2021

4,6,4'-Trimethylangelicin Photoactivated by Blue Light Might Represent an Interesting Option for Photochemotherapy of Non-Invasive Bladder Carcinoma: An In Vitro Study on T24 Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giulio Sturaro Research Topics

Disease

1	Non-Muscle Invasive Bladder Neoplasms 01/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 07/2017

Drug/Important Bio-Agent (IBA)

1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2021
1	4,4',6-trimethylangelicinIBA 01/2021
1	Biological ProductsIBA 01/2021
1	Methoxsalen (Oxsoralen)FDA Link 07/2017

Therapy/Procedure

1	Photochemotherapy (Photodynamic Therapy) 01/2021